Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL).

ABSTRACT:

SUBMITTER: Frei CR 

PROVIDER: S-EPMC11444894 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature